Crescent Biopharma CBIO
NASDAQ CBIO
$14.32 +0.06 (+0.42%)
At close: Oct 2, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) Cash & Current Investments (2013 - 2026)

Updated

Crescent Biopharma (CBIO) recorded Cash & Current Investments of $171.6 million in Q2 2026, up 12.4% from $152.65 million a year earlier but down 9.3% from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Cash & Current Investments (2013 - 2026) Analysis & Trends

At the end of FY2025, Crescent Biopharma reported Cash & Current Investments of $213.19 million, up 513.2% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 9.2% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $34.77 million in FY2024 (-16.8%), $41.79 million in FY2023 (-12.7%), $47.87 million in FY2022 (-47.0%) and $90.25 million in FY2021 (-34.1%).
  • Quarterly Cash & Current Investments has ranged from $14.4 million in Q3 2024 to $213.19 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has increased for five consecutive quarters, with growth averaging 320.0% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 825.7% in Q3 2025, against a decline of 70.9% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $189.2 million (Q1 2026), $213.19 million (Q4 2025) and $133.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Crescent Biopharma 397.47 Mn -309.83 Mn - 171.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 171.60 Mn
Mar 31, 2026 189.20 Mn
Dec 31, 2025 213.19 Mn
Sep 30, 2025 133.30 Mn
Jun 30, 2025 152.65 Mn
Mar 31, 2025 22.43 Mn
Dec 31, 2024 34.77 Mn
Sep 30, 2024 14.40 Mn
Jun 30, 2024 22.40 Mn
Mar 31, 2024 31.30 Mn
Dec 31, 2023 41.79 Mn
Sep 30, 2023 49.41 Mn
Jun 30, 2023 58.04 Mn
Mar 31, 2023 65.00 Mn
Dec 31, 2022 47.87 Mn
Sep 30, 2022 51.62 Mn
Jun 30, 2022 60.24 Mn
Mar 31, 2022 76.52 Mn
Dec 31, 2021 90.25 Mn
Sep 30, 2021 101.92 Mn
API Access

Crescent Biopharma Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CBIO&period=max&api_key=YOUR_API_KEY